Captor Therapeutics S.A. Strategic Asset Allocation Index
Captor Therapeutics S.A. strategic asset allocation index. Captor Therapeutics S.A. (CTX) has a Strategic Asset Allocation Index of 15.6% as of June 2023. Strategic assets (PP&E of zł8.69 Million plus long-term investments of zł-) total zł8.69 Million, measured against net assets of zł55.52 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Captor Therapeutics S.A. balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Captor Therapeutics S.A. (2021–2021)
Strategic asset allocation index of Captor Therapeutics S.A. from 2021 to 2021. This chart shows how Captor Therapeutics S.A.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 15.6%, representing strategic assets of zł8.69 Million against net assets of zł55.52 Million PLN. Check Captor Therapeutics S.A. tangible equity quality to evaluate the tangible quality of the company's equity base.
Captor Therapeutics S.A. Strategic Asset Allocation Index by Year (2021–2021)
Captor Therapeutics S.A. strategic asset allocation index by year from 2021 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Captor Therapeutics S.A. from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CTX stock market capitalisation.
| Year | SAAI | Strategic Assets (PLN) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 10.2% | zł12.61 Million | zł12.61 Million | zł- | zł124.20 Million | — |